The record → All 128 providers → Zealthy
Provider Dossier · try.getzealthy.com · Last verified 16 November 2026
Is Zealthy (Zelphie) legit?
Quick answerLast verified · GLP-1 Dossier Editorial Desk
Our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving Zealthy (Zelphie) (try.getzealthy.com), each linked to the original document below.
Published prices start at $135/mo; that figure is a membership or consultation fee, with medication billed separately.
It offers both compounded and FDA-approved GLP-1 options.
Disclosure: Unmonetized direct link (Zealthy has no commercial relationship with this site).
Yes, Zealthy (Zelphie) (try.getzealthy.com) is a real, operating US telehealth company that ships prescriptions, not a counterfeit card-skimming site. However, our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving the company, each linked to the original government or court document below.
On the clinical side, Zealthy offers both compounded and FDA-approved GLP-1 options at sharply different price tiers, and its published plan starts at $49 for the first month before renewing at $135/mo (medication billed separately).
Comparing Zealthy against compounded and branded providers with 0 actions on file
Zealthy has 1 regulatory or legal action documented below. For readers comparing transparent options in the same supply category before entering payment details, these providers have 0 actions on file and published monthly pricing:
- Website & Terms inspected
- try.getzealthy.com (Direct checkout & Terms of Service verified)
- Last price & terms read
- 16 November 2026 (Separate membership fee + medication billed on top)
- 503A / 503B pharmacy disclosure
- No partner compounding pharmacy named upfront before intake
- Public registries searched
- FDA CDER Warning Letters (2024–2026), Federal District Court Dockets (PACER / CourtListener), FTC Enforcement Actions, NAD Case Reports → 1 primary document linked below
- Researcher field note
- Operated by Zealthy, Inc. (getzealthy.com; also searched by consumers as Zelphie), founded by former Cerebral CEO Kyle Robertson. Charges a $135/month coaching membership ($39 first month) with medication billed separately on top: compounded semaglutide starts at $151/month and compounded tirzepatide at $216/month on top of the membership fee. Named as a corporate defendant alongside Kyle Robertson in the FTC/DOJ federal enforcement action United States v. Cerebral, Inc., Zealthy, Inc., et al. (S.D. Fla. No. 1:24-cv-21376), in which the Department of Justice moved for a federal asset freeze and receivership.
What it actually supplies
Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to.
Named on its own site (try.getzealthy.com): compounded semaglutide, compounded tirzepatide, branded GLP-1s subject to insurance coverage.
What regulators and courts have said
Every entry below links to its original document and identifies the source type. We publish what the official record states and nothing beyond it; a regulatory letter or lawsuit involving a company is not proof that an individual patient was harmed.
November 2024
In United States v. Cerebral, Inc., Zealthy, Inc., Gronk, Inc., and Kyle Robertson (S.D. Fla. Case No. 1:24-cv-21376), the Department of Justice and Federal Trade Commission filed a First Amended Complaint naming Zealthy, Inc. and its founder Kyle Robertson alongside Cerebral, alleging deceptive subscription enrollment, hidden medication charges on top of membership fees, and obstructive cancellation practices across Zealthy’s weight-loss and telehealth programs; DOJ subsequently moved for an immediate asset freeze and temporary receivership against Zealthy.
Other signals on file
Not regulatory or legal actions, and never counted as such. We log these items separately because they are sourced and relevant to prospective patients (complaint volumes, corporate and pharmacy disclosures, third-party lab reports, or commercial disputes).
August 2025
Industry reporting on DOJ’s August 2025 motion in S.D. Fla. seeking an immediate asset freeze and receivership over Zealthy, Inc. following allegations of continued deceptive billing and cancellation practices in its GLP-1 weight-loss program.
Corporate entity, pricing & cancellation terms
Operated by Zealthy, Inc. (getzealthy.com; also searched by consumers as Zelphie), founded by former Cerebral CEO Kyle Robertson. Charges a $135/month coaching membership ($39 first month) with medication billed separately on top: compounded semaglutide starts at $151/month and compounded tirzepatide at $216/month on top of the membership fee. Named as a corporate defendant alongside Kyle Robertson in the FTC/DOJ federal enforcement action United States v. Cerebral, Inc., Zealthy, Inc., et al. (S.D. Fla. No. 1:24-cv-21376), in which the Department of Justice moved for a federal asset freeze and receivership.
Go direct
The button below is a plain direct link to Zealthy and earns us nothing. Zealthy has no commercial arrangement with this desk and is documented under the exact same verification rules as companies that do pay.
Visit Zealthy (try.getzealthy.com) →Lower advertised starting prices
Providers advertising a lower monthly entry figure. Check each dossier before comparing two numbers: the headline price alone does not tell you whether medication is included.
If you prefer FDA-approved medication only
These clinics prescribe FDA-approved brand-name drugs only and currently have 0 regulatory actions on file here.
Side-by-side records
Compared with the alternatives
Direct dossier comparisons for the providers patients most frequently weigh against Zealthy.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Reference notes
Zealthy (Zelphie): key questions answered
- Is Zealthy (Zelphie) (try.getzealthy.com) legit or a scam? What does the public record show?
- Yes. Zealthy (Zelphie) (try.getzealthy.com) is an active, operating US weight-loss telehealth company. It offers both compounded GLP-1 formulations and FDA-approved brand-name drugs at distinct price points. Our regulatory sweep matched 1 primary-sourced regulatory or legal action on file: In United States v. Cerebral, Inc., Zealthy, Inc., Gronk, Inc., and Kyle Robertson (S.D. Fla. Case No. 1:24-cv-21376), the Department of Justice and Federal Trade Commission filed a First Amended Complaint naming Zealthy, Inc. and its founder Kyle Robertson alongside Cerebral, alleging deceptive subscription enrollment, hidden medication charges on top of membership fees, and obstructive cancellation practices across Zealthy’s weight-loss and telehealth programs; DOJ subsequently moved for an immediate asset freeze and temporary receivership against Zealthy.
- Does Zealthy sell compounded or FDA-approved weight loss medication?
- Compounded and branded. Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to. Specifically named on try.getzealthy.com: compounded semaglutide, compounded tirzepatide, branded GLP-1s subject to insurance coverage.
- What are Zealthy weight loss pricing, hidden fees, and cancellation terms?
- Zealthy (try.getzealthy.com) publishes weight-loss plans starting at $135 per month, with the medication itself billed separately at the pharmacy, alongside a promotional or bundle rate of $49. Contract and billing terms: $135/month membership, discounted to $49 for the first month; $39 initial consultation; medication separate; cancel anytime. Operated by Zealthy, Inc. (getzealthy.com; also searched by consumers as Zelphie), founded by former Cerebral CEO Kyle Robertson. Charges a $135/month coaching membership ($39 first month) with medication billed separately on top: compounded semaglutide starts at $151/month and compounded tirzepatide at $216/month on top of the membership fee. Named as a corporate defendant alongside Kyle Robertson in the FTC/DOJ federal enforcement action United States v. Cerebral, Inc., Zealthy, Inc., et al. (S.D. Fla. No. 1:24-cv-21376), in which the Department of Justice moved for a federal asset freeze and receivership.
- What compounding or fulfillment pharmacy does Zealthy use?
- Zealthy (try.getzealthy.com) states that compounded GLP-1 prescriptions are fulfilled through state-licensed 503A or 503B compounding pharmacies, without listing specific partner pharmacy names on its public pre-checkout pages. Patients can verify the exact compounding pharmacy, address, and state board license number printed on the prescription vial label upon delivery.
- Are there FDA warning letters, lawsuits, or regulatory complaints against Zealthy?
- Yes. We hold 1 primary-sourced regulatory or legal action on record involving Zealthy (try.getzealthy.com): In United States v. Cerebral, Inc., Zealthy, Inc., Gronk, Inc., and Kyle Robertson (S.D. Fla. Case No. 1:24-cv-21376), the Department of Justice and Federal Trade Commission filed a First Amended Complaint naming Zealthy, Inc. and its founder Kyle Robertson alongside Cerebral, alleging deceptive subscription enrollment, hidden medication charges on top of membership fees, and obstructive cancellation practices across Zealthy’s weight-loss and telehealth programs; DOJ subsequently moved for an immediate asset freeze and temporary receivership against Zealthy. Every entry links directly to the primary FDA, NAD, or court document on this page. Separately from regulatory enforcement, our file notes 1 other sourced signal: Industry reporting on DOJ’s August 2025 motion in S.D. Fla. seeking an immediate asset freeze and receivership over Zealthy, Inc. following allegations of continued deceptive billing and cancellation practices in its GLP-1 weight-loss program.